Key facts
- This page summarizes Jess Roper's Form 3 filing for REVELATION BIOSCIENCES, INC. (REVB).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 20 Jan 2022, 17:04.
Jess Roper - 10 Jan 2022 Form 3 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)
- Reporting relationship
- Director
- Issuer ticker
- REVB
- Reported as of
- 10 Jan 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 20 Jan 2022, 17:04:22 UTC
- Prior SEC filing
- 14 Jun 2021
- Next SEC filing
- 02 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ J.P. Galda, as attorney-in-fact for Jess Roper
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jess Roper filed Form 3 for REVELATION BIOSCIENCES, INC. (REVB) on 20 Jan 2022.
Change
- Previous filing in this sequence was filed on 14 Jun 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
REVB
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 10 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,422
- Exercise price
- Footnotes
- F1, F2, F3
REVB
holding
Derivative
Restricted Stock Unit
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 10 Jan 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,422
- Exercise price
- Footnotes
- F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
These RSUs vest quarterly over a one-year period, with the first quarterly vesting scheduled to occur on January 31, 2021.
Footnote F2
RSUs do not expire; they either vest or are canceled prior to vesting date.
Footnote F3
Each RSU converts into common stock on a one-for-one basis.
Footnote F4
These RSUs vest quarterly over a one-year period, with the first quarterly vesting scheduled to occur on May 23, 2021.
SEC remarks
Exhibit 24 - Power of Attorney.